Lv11
48 积分 2024-02-12 加入
Novel GPC3 N-terminal bispecific antibody exhibits dual anti-tumor effect against tumor cells
3小时前
待确认
A novel bispecific antibody as an immunotherapeutic agent in hepatocellular carcinoma
19天前
已完结
Neoantigen-targeted CD8+ T cell responses with PD-1 blockade therapy
25天前
已完结
Predicting human subcutaneous bioavailability of monoclonal antibodies using an integrated in-vitro/in-silico approach
2个月前
已完结
GenSci120, a humanized PD-1 agonistic monoclonal antibody, enhances the binding of both PD-L1 and PD-L2 to PD-1, and mitigates the symptoms of GVHD in a mouse model
2个月前
已完结
Non-specificity as the sticky problem in therapeutic antibody development
3个月前
已完结
Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancers
4个月前
已完结
FDA approves first biparatopic antibody therapy
4个月前
已关闭
Targeting the TNF and TNFR superfamilies in autoimmune disease and cancer
6个月前
已完结
Obexelimab in Systemic Lupus Erythematosus With Exploration of Response Based on Gene Pathway Co-Expression Patterns: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial
6个月前
已完结
皖公网安备34019202002308
